医疗保健和生命科学

  • 荷兰和骑士的医疗保健和生命科学团队协助全方位的行业参与者,从供应商,付款人和网络到制造商,分销商和供应商,在其运营的各个方面。
  • 我们的许多团队成员都担任内部医疗保健企业,协会和政府的内部顾问,为我们提供了对该行业的深入了解和客户面临的挑战。
  • 我们的团队包括律所的律师,他们专注于影响我们医疗保健客户的法律领域,包括合规、诉讼和纠纷解决、医疗保健改革、监管法律、立法行动、公司、税收和一般交易问题。
血压

概述

今天在法律和监管领域发生的快速发生变化,塑造了医疗保健法律创建了一系列合规性,交易和诉讼问题,这可以使您的日常运营变得越来越复杂。

作为美国最大的医疗保健和生命科学措施之一,荷兰省和骑士的专业医疗保健律师和专业人士适用于该行业的深入了解和公司的资源,以促进和保护您的兴趣。新万博manbetx官网下载

实践经验的优势

你将受益于一个律师团队,他们了解你面临的要求和压力。许多人曾担任多个医疗保健企业、协会和政府的内部顾问。他们的行业职位包括:

  • 前律师卫生计划,医院,药房链,医疗保健认证者和其他利益攸关方
  • 曾在一家大型制药公司的全球业务发展部门担任内部顾问
  • 前联邦和州检察官
  • 提供商和健康保险公司贸易协会的内部律师
  • 国会前成员,机构官员和国会山山的工作人员制定了管理您的业务的法律法规

不同的客户基础

丰富的医疗保健法律经验使Holland&Knight在全系列医疗相关的业务方面的选择合伙人 - 从提供商,付款人和网络到制造商,分销商和供应商。

广泛的行业知识

无论您的问题涉及合规、诉讼和争议解决、虚假申诉法辩护、监管法律、立法行动、公司、税收或一般交易问题,Holland & Knight的医疗和生命科学律师都具有您所需的经验和敏锐触觉。支持你的团队是一个非常有能力的、当前的、与你的行业相关的团队。

综合实践支持

及时了解新兴趋势和立法问题可能是令人生畏的。通过绘制我们的综合实践团体和基于行业的团队,荷兰和骑士可以帮助您导航医疗保健行业的法律复杂性。医院的所有者和运营商,临床实验室,长期护理和其他与健康有关的设施为我们致力于对我们的合法代表充满活力,积极主动和高效。Holland&Knight的健康隐私团队劝告HIPAA法律和安全问题的客户。我们的多学科方法还使我们能够提供高效的支持,以帮助您应对生命科学持续发展所产生的挑战和问题。

保持联系良好

Holland & Knight律师努力与政府和州民选官员、我们服务的行业以及我们生活和工作的全国各地的商界建立关系。manbetx万博app下载无论您是否需要在商业交易谈判、确保遵守公共卫生法律政策、HIPAA法律和隐私标准方面的员工培训,还是通过立法程序推进您的项目,我们利用这些关系的能力为您的业务产生强大的、持续的结果。

领先的律师在你身边

医疗保健和生命科学团队已在许多出版物中得到认可。

  • Holland & Knight获得了全国一流的排名2021美国新闻 - 最好的律师®“最佳律师事务所”医疗保健法指南,和大都会一级排名迈阿密和塔拉哈西
  • 2020钱伯斯美国指南对佛罗里达州和马萨诸塞州的Holland & Knight合伙人进行了医疗法律排名。
  • 医疗保健和生命科学产业部门集团联合椅名为2020年全明星客户服务BTI咨询集团
  • Holland & Knight收到最高认可美国律师协会健康法律部分-年度十大律师事务所在东北部、华盛顿和东南部的排名中。
  • 荷兰和骑士排名第一最大的25家医疗保健律师事务所全国范围内现代医疗保健杂志。

案例研究

多媒体

Members of Holland & Knight's Public Policy & Regulation Group host a webinar covering Community Project Funding (CPF), formerly known as earmarks. Team members share insights on the new process as well as guidance on steps you can take to have your project considered.

\n

Our bipartisan group of attorneys and professionals drill down on details and programs available for the following subcommittees:

\n\n

Duration: 01:06:00

","link":{"label":"Insights and Outlook on Community Project (Earmark) Funding","url":"/en/insights/media-entities/2021/04/insights-and-outlook-on-community-project-earmark-funding","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2021/04/insights-and-outlook-on-community-project-earmark-funding","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2021/03/media_stavinsky_jnf_still.jpg","alt":"U.S. & Israeli Innovations in the Life Sciences: Part 2"},"description":"

Israel Practice co-chair Meital Stavinsky moderated a webinar hosted by the Jewish National Fund discussing the potential COVID-19 \"cure\" Allocetra developed by Enlivex Therapeutics from Chief Scientific & Medical Officer Dror Mevorach. The panel consisted of industry professionals from the BioTech and Pharmaceutical sectors of Israel and Miami. The program also included a discussion with a Miami & Israeli BioTech Panel featuring Isaac Litman, Founder & CEO of Neteera Technologies, Dr. Osnat Sela Tavor, CTO of Nanose Medical, and Andrew Satz, CEO of EVQLV.

\n

Duration 1:26:15

","link":{"label":"U.S. & Israeli Innovations in the Life Sciences: Part 2","url":"/en/insights/media-entities/2021/03/us-israeli-innovations-in-the-life-sciences-part-2","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2021/03/us-israeli-innovations-in-the-life-sciences-part-2","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2021/02/mediafirst100dayshcstill.png","alt":"First 100 Days Title Slide"},"description":"In the first episode of our Public Policy & Regulation Group's \"The First 100 Days of the Biden Administration\" podcast series, Senior Policy Advisor Miranda Franco leads a discussion with attorney Robert Bradner and Senior Public Affairs Advisor Suzanne Joy on the healthcare priorities and landscape facing the new administration. They discuss current issues and provide listeners with an inside look on what to expect in the upcoming months.","link":{"label":"Podcast: Healthcare Priorities and Landscape","url":"/en/insights/media-entities/2021/02/podcast-healthcare-priorities-and-landscape","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2021/02/podcast-healthcare-priorities-and-landscape","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/10/media_preelection_series_healthcare_recording_still.jpg","alt":"Pre-Election Webinar Series: Healthcare recording still"},"description":"

Holland & Knight's experienced lobbyists and attorneys are focusing on the policy implications of the upcoming 2020 elections. The fifth program in this series focused on healthcare and life sciences.

\n

Partner Michael Werner focused on issues affecting drug and biotech companies such as those relating to possible regulation of drug prices, Medicare and Medicaid reimbursement, and regulatory reforms.

\n

Partner Lisa Hawke addressed the potential for major changes to the healthcare system and the Affordable Care Act following the election, impacts on our public health, emergency preparedness and safety-net systems resulting from COVID-19, and the effects of all of these possible changes on healthcare providers and patients.

\n

View the presentation materials.

\n

Duration: 1:00:38

","link":{"label":"Election 2020: Potential Impacts Series - Healthcare & Life Sciences","url":"/en/insights/media-entities/2020/10/election-2020-potential-impacts-series-healthcare","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/10/election-2020-potential-impacts-series-healthcare","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/media_audio_still.jpg","alt":"sound waves"},"description":"

Healthcare and Digital Privacy Partner Shannon Hartsfield joined the DarshanTalks podcast for a discussion on the Health Insurance Portability and Accountability Act (HIPAA) and its application as digital health become more common. Their conversation covered areas such as misconceptions surrounding HIPAA's coverage, the relationship between HIPAA and similar state laws, and how healthcare providers can use digital platforms while still complying with HIPAA and other privacy requirements.

\n

Duration: 21:35

","link":{"label":"HIPAA and Digital Health Mistakes: An Interview With Shannon Hartsfield","url":"/en/insights/media-entities/2020/10/hipaa-and-digital-health-mistakes-an-interview-with-shannon-hartsfield","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/10/hipaa-and-digital-health-mistakes-an-interview-with-shannon-hartsfield","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/08/media_hhs_knocks_at_the_door_still.jpg","alt":"When HHS Knocks at the Door still"},"description":"Healthcare & Life Sciences Partners Jeremy Sternberg and Michael Manthei joined PYA for a webinar offering an overview of the CARES Act Provider Relief Fund and its reporting requirements. Although the funds function similarly to grants in that they do not require repayment, their use must be carefully documented, and audits are possible. This webinar covered the attestation requirements and areas of use, potential challenges for rural hospitals, the implications of non-compliance or false claims, and ways to demonstrate attestation made in good faith, should issues arise.
\n
\nDuration: 1:02:17","link":{"label":"When HHS Knocks at the Door — Preparing for Provider Relief Fund Attestation Defense","url":"/en/insights/media-entities/2020/08/when-hhs-knocks-at-the-door-preparing-for-provider-relief-fund","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/08/when-hhs-knocks-at-the-door-preparing-for-provider-relief-fund","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/06/mediapalmastill.jpg","alt":"Your Rights as a Medical Professional during COVID-19"},"description":"

Senior Counsel Leslie Palma participated as speaker in a webinar on medical practitioner’s rights during the COVID-19 pandemic. The session offered legal medical advice and answered many sanitary related questions for industry professionals.

\n

Duration 47:28

","link":{"label":"Your Rights as a Medical Professional During COVID-19","url":"/en/insights/media-entities/2020/06/your-rights-as-a-medical-professional-during-covid19","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/06/your-rights-as-a-medical-professional-during-covid19","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/04/cares_act_media_still.jpg","alt":"Doctor holding stethescope"},"description":"

Holland & Knight's healthcare professionals presented a webinar about the $2.2 trillion Coronavirus Air, Relief, and Economic Security Act (CARES Act) and the opportunities and resources it provides for the healthcare industry.
\n
\nTopics include:

\n
    \n
  • Alleviating Financial Strain - What hospitals and providers need to consider to pursue CARES Act emergency funds and loan opportunities
  • \n
  • Unprecedented Flexibility - How to take advantage of the new waivers and regulatory flexibilities to respond to COVID-19
  • \n
  • Reimbursement Relief - Overview of CARES Act provisions that suspend reduced reimbursement
  • \n
  • Insights into COVID-19 Phase 4 - Congress is already beginning to outline elements of a fourth relief and support bill
  • \n
\n

This recorded discussion  will benefit hospitals, healthcare professionals and businesses, clinics, their counsel and contractors who perform work within the industry.

","link":{"label":"CARES Act: Funding, Relief, Changes for Hospitals and Providers","url":"/en/insights/media-entities/2020/04/cares-act-funding-relief-changes-for-hospitals-and-providers","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/04/cares-act-funding-relief-changes-for-hospitals-and-providers","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/media_audio_still.jpg","alt":"sound waves"},"description":"Co-Chair of the firm's Israel Practice Meital Stavinsky spoke at the Sustainability & Digitalization Leaders (SDL) Executive Leadership Summit: Commercializing Change in Agtech. Ms. Stavinsky discussed how cannabis-tech transformed Israel from a start-up nation into an agtech nation and speculates what this means for the future of agtech in Israel. ","link":{"label":"How Cannabis-Tech Transformed Israel from a Start-Up Nation into an AgTech Nation","url":"/en/insights/media-entities/2019/10/how-cannabistech-transformed-israel","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2019/10/how-cannabistech-transformed-israel","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2019/02/avoiding-hipaa-headaches-and-hassles/videostillimage/mediastillhipaa-headaches.jpg","alt":"Avoiding HIPAA Headaches and Hassles"},"description":"

All healthcare lawyers need to know about HIPAA and how it affects the healthcare industry. In this program, attorneys Shannon Hartsfield and Eddie Williams will talk about key HIPAA concepts that every lawyer should know. Along with key concepts, there are some areas that can be sticky and have compliance pitfalls. The attorneys will address those areas and how to overcome or avoid them for your clients. Recent regulatory developments have taken shape regarding HIPAA and the presenters will cover those here for you.

Duration: 1 hour 6 minutes

","link":{"label":"Avoiding HIPAA Headaches and Hassles","url":"/en/insights/media-entities/2019/02/avoiding-hipaa-headaches-and-hassles","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2019/02/avoiding-hipaa-headaches-and-hassles","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2018/11/midterm-post-election-briefing-2018/videostillimage/mediapostelectionbriefingstill.jpg","alt":"Midterm Post Election Briefing 2018"},"description":"

Bloomberg Government and Holland & Knight's Public Policy & Regulation Group presented a live stream of our post-election briefing, during which panelists provided in-depth analysis of the 2018 midterm elections results. During the program, our featured panelists explored what the results might mean for key industry sectors, including trade, infrastructure and transportation, energy and environment, and healthcare and life sciences.

View the slides from the program and follow the conversation on Twitter with #askBGOVHK.

What Happened in 2018?

\"\"
Watch the video »

  • Greg Giroux, Reporter, Bloomberg Government

Transportation and Infrastructure

\"\"
Watch the video »

  • Heather Rothman, News Director, Bloomberg Government 
  • Shaun Courtney, Federal Transportation Reporter, Bloomberg Government 
  • Michael Friedberg, Senior Counsel, Holland & Knight 
  • Shawna Francis Watley, Senior Policy Advisor, Holland & Knight

Healthcare/Pharmaceuticals

\"\"
Watch the video »

  • Heather Rothman, News Director, Bloomberg Government
  • Alex Ruoff, Health Policy Reporter, Bloomberg Government
  • Michael Werner, Partner, Holland & Knight
  • Miranda Franco, Senior Policy Advisor, Holland & Knight

Energy and Environment

 \"\"
Watch the video »

  • Abby Smith, Reporter, Bloomberg Environment 
  • Dimitrios Karakitsos, Partner, Holland & Knight 
  • Benjamin Dunham, Senior Policy Advisor, Holland & Knight

Trade and Tariffs

\"\"
Watch the video »

  • Loren Duggan, Editorial Director, Bloomberg Government 
  • Sarah Babbage, Legislative Analyst, Bloomberg Government 
  • Ronald Oleynik, Partner, Holland & Knight 
  • Jim Davis, Partner, Holland & Knight
","link":{"label":"Midterm Post Election Briefing 2018","url":"/en/insights/media-entities/2018/11/midterm-post-election-briefing-2018","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2018/11/midterm-post-election-briefing-2018","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2017/11/what-the-fdas-new-framework-means-for-regenerative/videostillimage/mediaaudiostill.jpg","alt":"What the FDA's New Framework Means for Regenerative Therapies"},"description":"

The FDA recently passed a new policy framework governing the development and oversight of regenerative medicine. Attorney Michael Werner discussed these new policies and what they mean for the industry at large on an episode of RARECast.

Duration: 27:20

","link":{"label":"What the FDA's New Framework Means for Regenerative Therapies","url":"/en/insights/media-entities/2017/11/what-the-fdas-new-framework-means-for-regenerative","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2017/11/what-the-fdas-new-framework-means-for-regenerative","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2017/06/straight-from-the-cutters-mouth-a-retina-podcast/videostillimage/mediaaudiostill.jpg","alt":"Straight from the Cutter’s Mouth: A Retina Podcast"},"description":"

On this Retina Podcast, Litigation Attorneys Joshua Levenson and Ben Taormina, discuss various legal matters including medical malpractice, the importance of accurate documentation in the medical record and employment contracts.

Duration: 40:34

","link":{"label":"Straight from the Cutter’s Mouth: A Retina Podcast","url":"/en/insights/media-entities/2017/06/straight-from-the-cutters-mouth-a-retina-podcast","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2017/06/straight-from-the-cutters-mouth-a-retina-podcast","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2016/08/stem-cell-treatment-promised-by-clinics-but-has-it/videostillimage/mediaaudiostill.jpg","alt":"Stem Cell Treatment Promised by Clinics, but Has It Been Proven?"},"description":"As stem-cell research booms, mainstream scientists say it will be years before these types of therapies are proven safe and effective. The Wall Street Journal's Melinda Beck explains on Lunch Break with Tanya Rivero along with Holland & Knight Partner and Alliance for Regenerative Medicine's Michael Werner.","link":{"label":"Stem Cell Treatment Promised by Clinics, but Has It Been Proven?","url":"/en/insights/media-entities/2016/08/stem-cell-treatment-promised-by-clinics-but-has-it","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2016/08/stem-cell-treatment-promised-by-clinics-but-has-it","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2014/11/2014-election-outcomes-and-impacts/videostillimage/mediaelectionoutcomes2014still.jpg","alt":"2014 Election Outcomes and Impacts"},"description":"On November 5, 2014, Holland & Knight's Public Policy and Regulation Group hosted a webinar titled \"2014 Election Outcomes and Impacts.\" The program was presented by Public Policy & Regulation Group Leader Rich Gold, along with Senior Policy Advisor Kerry Feehery, Partners Paul Bock and Kathryn Lehman and Senior Policy Advisor Karl Koch. These experienced attorneys and lobbyists provided insights on the approaches of the Administration and the new House and Senate majorities and minorities on key issues, such as the budget, healthcare, tax reform, cybersecurity, patent reform, and immigration, as well as potential committee chairs and the impact on pending legislation.","link":{"label":"2014 Election Outcomes and Impacts","url":"/en/insights/media-entities/2014/11/2014-election-outcomes-and-impacts","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2014/11/2014-election-outcomes-and-impacts","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2011/05/cms-fda-and-the-parallel-review-process/videostillimage/mediacmsfdastill.jpg","alt":"CMS, FDA and the “Parallel Review Process”"},"description":"

VIEW WEBCAST
Duration: 8 min.

Drug companies and medical device manufacturers must do their homework before undergoing a “parallel review process” of the Food and Drug Administration and the Center for Medicare & Medicaid Services. That’s what Partner Michael Gaba, leader of the firm’s national Healthcare and Life Sciences Team, notes in a webinar about the new joint review system created by the two agencies.

Originally recorded as part of the Bureau of National Affair’s “Thought Leadership” video series, Mr. Gaba says one hurdle for companies to overcome is the agencies’ different missions and styles of review. “The FDA, by its nature, reviews products in a very confidential manner, maintaining the proprietary status of the information submitted by companies,” Mr. Gaba says. “CMS, by comparison, when undertaking a coverage process, does so in a very public manner.”

Mr. Gaba also discusses if the parallel review process can shorten the time for a product to go to market, and whether it can spur venture capital investment in innovative technologies.

Note: Reproduced with permission from the Bureau of National Affairs, \"BNA Insights Health Care,\" BNA Video Insights. Copyright 2011 by The Bureau of National Affairs, Inc. (800-372-1033) www.bna.com

","link":{"label":"CMS, FDA and the “Parallel Review Process”","url":"/en/insights/media-entities/2011/05/cms-fda-and-the-parallel-review-process","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2011/05/cms-fda-and-the-parallel-review-process","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2009/08/address-by-fda-commissioner-margaret-hamburg-md/videostillimage/mediaaddressbyfdacommissionerstill.jpg","alt":"Address by FDA Commissioner Margaret Hamburg, M.D."},"description":"

VIEW WEBCAST
Duration: 37 min.

FDA Commissioner Margaret A. Hamburg speaks on the Agency's use of enforcement to promote public health at the Food and Drug Law Institute on August 6, 2009.

Holland & Knight's Health Law & Life Sciences lawyer Michael Gaba is featured during the question and answer portion of the event.

","link":{"label":"Address by FDA Commissioner Margaret Hamburg, M.D.","url":"/en/insights/media-entities/2009/08/address-by-fda-commissioner-margaret-hamburg-md","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2009/08/address-by-fda-commissioner-margaret-hamburg-md","target":"","rel":""}}]">

狗万软件

Holland & Knight Alert"],"link":{"label":"N.J. High Court Rules on Employer Obligations Under State Medical Marijuana Act","url":"/en/insights/publications/2021/05/nj-high-court-rules-on-employer-obligations-under-state-medical","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/05/nj-high-court-rules-on-employer-obligations-under-state-medical","target":"","rel":""},"icon":{"url":null,"alt":null},"image":{"url":null,"alt":null},"date":"May 6, 2021","readingtime":"6 Minutes","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"CMS Releases FY 2022 IPPS and LTCH Proposed Rule","url":"/en/insights/publications/2021/05/cms-releases-fy-2022-ipps-and-ltch-proposed-rule","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/05/cms-releases-fy-2022-ipps-and-ltch-proposed-rule","target":"","rel":""},"icon":{"url":"/-/media/images/icons/articleicon__doctor.svg","alt":"Doctor"},"image":{"url":null,"alt":null},"date":"May 4, 2021","readingtime":"15 Minutes","source":null},{"metaData":["Law360"],"link":{"label":"Averting Risk in Back-To-Work Vaccine and Screening Policies","url":"/en/insights/publications/2021/05/averting-risk-in-back-to-work-vaccine-and-screening-policies","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/05/averting-risk-in-back-to-work-vaccine-and-screening-policies","target":"","rel":""},"icon":{"url":null,"alt":null},"image":{"url":null,"alt":null},"date":"May 3, 2021","readingtime":"","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"COVID-19: Nuevas Medidas Sanitarias en la Ciudad de México y el Estado de México","url":"/en/insights/publications/2021/04/covid19-nuevas-medidas-sanitarias-en-la-ciudad-de-mexico","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/04/covid19-nuevas-medidas-sanitarias-en-la-ciudad-de-mexico","target":"","rel":""},"icon":{"url":null,"alt":null},"image":{"url":null,"alt":null},"date":"29 de abril de 2021","readingtime":"6 Minutes","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"Healthcare Law Update: April 2021","url":"/en/insights/publications/2021/04/healthcare-law-update-april-2021","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/04/healthcare-law-update-april-2021","target":"","rel":""},"icon":{"url":"/-/media/images/icons/articleicon__doctor.svg","alt":"Doctor"},"image":{"url":null,"alt":null},"date":"April 16, 2021","readingtime":"16 Minutes","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"DOL Releases Guidance and Model Notices for New COBRA Premium Subsidy","url":"/en/insights/publications/2021/04/dol-releases-guidance-and-model-notices-for-new-cobra-premium-subsidy","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/04/dol-releases-guidance-and-model-notices-for-new-cobra-premium-subsidy","target":"","rel":""},"icon":{"url":null,"alt":null},"image":{"url":null,"alt":null},"date":"April 13, 2021","readingtime":"4 Minutes","source":null}]">

即将来临的事件

新闻和标题

EdSource","In the Headlines"],"link":{"label":"Many Colleges Require Vaccines Immediately, but CSU and UC Stick With Plan to Wait on FDA","url":"/en/news/intheheadlines/2021/05/many-colleges-require-vaccines-immediately-csu-and-uc-to-wait","AbsoluteUrl":"//www.efaxnow.com/en/news/intheheadlines/2021/05/many-colleges-require-vaccines-immediately-csu-and-uc-to-wait","target":"","rel":""},"icon":{"url":null,"alt":null},"image":null,"date":"May 6, 2021","readingtime":null,"source":null},{"metaData":["","The Parallax View","In the Headlines"],"link":{"label":"How A HIPAA ‘Safe Harbor’ Could Change Data Breach Consequences","url":"/en/news/intheheadlines/2021/04/how-a-hipaa-safe-harbor-could-change-data-breach","AbsoluteUrl":"//www.efaxnow.com/en/news/intheheadlines/2021/04/how-a-hipaa-safe-harbor-could-change-data-breach","target":"","rel":""},"icon":{"url":"/-/media/images/icons/articleicon__doctor.svg","alt":"Doctor"},"image":null,"date":"April 27, 2021","readingtime":null,"source":null},{"metaData":["","South Florida Sun-Sentinel, Miami Herald, Tampa Bay Times","In the Headlines"],"link":{"label":"Going Back To The Office? How Most Employers Are Handling COVID Vaccines For Workers","url":"/en/news/intheheadlines/2021/04/going-back-to-the-office-how-most-employers-are-handling-vaccines","AbsoluteUrl":"//www.efaxnow.com/en/news/intheheadlines/2021/04/going-back-to-the-office-how-most-employers-are-handling-vaccines","target":"","rel":""},"icon":{"url":null,"alt":null},"image":null,"date":"April 14, 2021","readingtime":null,"source":null}]">